Abstract
P-025: Investigating the effect of irreversible proteasome inhibitor carfilzomib in in vivo models of cardiometabolic syndrome and early stage HFrEFP: prophylactic role of metformin
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have